INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 27 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q4 2016. The put-call ratio across all filers is 4.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $7,000 | -90.7% | 15,497 | -83.6% | 0.00% | – |
| Q4 2017 | $75,000 | -38.5% | 94,244 | -23.8% | 0.00% | – |
| Q3 2017 | $122,000 | -73.4% | 123,758 | -43.6% | 0.00% | – |
| Q2 2017 | $458,000 | +44.9% | 219,304 | +74.6% | 0.00% | – |
| Q1 2017 | $316,000 | -23.3% | 125,593 | -13.5% | 0.00% | – |
| Q4 2016 | $412,000 | +198.6% | 145,172 | +123.6% | 0.00% | – |
| Q3 2016 | $138,000 | +79.2% | 64,934 | +73.3% | 0.00% | – |
| Q1 2016 | $77,000 | -73.4% | 37,468 | -73.6% | 0.00% | – |
| Q4 2015 | $290,000 | +2.5% | 142,073 | -8.6% | 0.00% | – |
| Q3 2015 | $283,000 | -22.9% | 155,499 | +24.6% | 0.00% | – |
| Q2 2015 | $367,000 | +948.6% | 124,846 | +883.0% | 0.00% | – |
| Q1 2015 | $35,000 | -81.4% | 12,700 | -84.7% | 0.00% | – |
| Q4 2014 | $188,000 | -25.7% | 83,204 | -1.1% | 0.00% | – |
| Q3 2014 | $253,000 | +79.4% | 84,134 | +128.3% | 0.00% | – |
| Q2 2014 | $141,000 | – | 36,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atria Investments, Inc | 75,895 | $159,000 | 0.02% |
| FIRST FOUNDATION ADVISORS | 100,900 | $212,000 | 0.02% |
| Argent Trust Co | 15,121 | $32,000 | 0.01% |
| Acrospire Investment Management LLC | 1,500 | $3,000 | 0.00% |
| Virtu KCG Holdings LLC | 33,485 | $70,000 | 0.00% |
| SIMPLEX TRADING, LLC | 9,846 | $20,000 | 0.00% |
| Advisor Group, Inc. | 11,791 | $25,000 | 0.00% |
| Hudson Bay Capital Management LP | 10,000 | $21,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,038 | $2,000 | 0.00% |